Health ❯ Pharmaceuticals

Drug Safety

Contaminated Drugs Counterfeit Drugs Quality Control Adverse Effects Contaminated Products Regulatory Compliance Contamination Adulteration Regulatory Actions Product Recalls Recalls Regulation Toxicology Regulations Mifepristone Fentanyl Toxic Substances FDA Regulations Regulatory Affairs Clinical Trials Cough Syrups Acetaminophen Side Effects Contaminated Medications Contaminants Drug Recalls GLP-1 Drugs Medication Recall Counterfeit Medicines Abortion Pills Abortion Drugs Cough Syrup Counterfeit Medications Regulatory Issues Adverse Drug Reactions Legal Issues Manufacturing Practices Contaminated Medicines Prescription Medications Medication Recalls Market Regulation Quality Assurance Adverse Events Cancer Risks Cancer Risk Contraceptives Carcinogens Health Risks FDA Approval Drug Storage Hormonal Therapies Contamination Issues Mental Health Tylenol Adulterated Products Pregnancy Health Pregnancy Risks Acetaminophen Risks Compounded Medications Spurious Medicines Chemical Abortion Prenatal Health Compounded Drugs Pharmacovigilance Diethylstilbestrol Manufacturing Standards Contaminated Substances Unauthorized Medications Compliance Product Liability Sodium Valproate Licensing Market Withdrawal Regulatory Bodies Controlled Substances Inspection Procedures Medication Side Effects Manufacturing Inspections Chirality in Drugs Adverse Drug Events Litigation Weight Loss Drugs Medication Review Advertising Practices Opioids Vaccine Ingredients Overdose Risks Abortifacient Drugs Market Withdrawals Environmental Health Drug Importation Organ Damage Cyanide Poisoning Zantac Adverse Reactions Alternative Treatments Ivermectin Anticholinergic Drugs Clinical Trial Risks Product Tampering

FDA Elevates Vitruvias Thyroid Tablet Recall to Class I

The agency says a single lot was found potentially superpotent, creating a reasonable probability of serious harm.

Lawsuits Over GLP‑1 Drugs Mount After Reports of Rare Sudden Vision Loss

Xenon Files FDA New Drug Application for Azetukalner After Pause in Depression Trials

Company Recalls Three Lots of Multi‑Dose Epinephrine Vials Over Contamination Concerns

RFK Jr. Walks Off Tampa Event After Question on $1 Million Kratom Donation

Senate Report Says Mifepristone Makers Fail to Enforce FDA Safety Rules

Vitruvias Recalls Lot of Thyroid Tablets Over 'Superpotent' Test Results

Lilly Sues Six U.S. Firms Over Black‑Market Sales of Experimental Drug Retatrutide

Virginia Judge Orders FDA to Reconsider 2023 Abortion‑Pill Restrictions

Manufacturer Recalls Generic Zyrtec Over Possible Ranitidine Contamination

FDA Classifies Chlorthalidone Recall as Class II

Severe GLP‑1 Overdoses Rise as Online Access and Compounded Vials Expand

More Than 370,000 Duloxetine Bottles Recalled Over Nitrosamine Contamination

FDA Orders New Kidney Warning for Orlistat Weight‑Loss Pills

Zealand Pharma Shares Tumble After Survodutide Phase III Shows High Dropouts

FDA Launches Retrospective Safety Study of Mifepristone

Viatris Recalls One Lot of Xanax XR Nationwide After Tablets Fail FDA Dissolution Test

FDA Elevates Nationwide Cough-Drop Recall to Class II

Wadagni Poised to Win Benin Presidency With 94% in Preliminary Count

Law Firms Press Soleno Investors to Seek Lead Role in Securities Suit by May 5